Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients | MicrobiomeTrials← Back to trialsNCT05413343
Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients
CompletedOBSERVATIONAL
Trial Details
Start: 2021-06-01Est. Completion: 2023-09-08
Enrollment target: 33 participants Locations- The First Affiliated Hospital,College of Medicine,Zhejiang University, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
AML, Adult RecurrentALL, Recurrent, AdultMDS
The goal of this clinical trial is to test BSB-1001 which is a new type of cellular therapy to treat blood cancers (AML,…
Duarte, United StatesCompleted Sep 8, 2026
InfectionsInfections - BacterialViral InfectionSepsis
The aim of this study is to improve the medical care of patients with infections for which the cause cannot be clearly i…
Basel, SwitzerlandCompleted May 31, 2018